Today, at the Global Summit: Health and Prosperity through Immunisation in Brussels, world leaders pledged support for Gavi, the Vaccine Alliance, leading to a total of more than US$ 9 billion secured against a targeted US$ 11.9 billion budget for its next five-year strategic period from 2026 to 2030 (Gavi 6.0). Additional donor commitments are expected in the coming months.

The Summit also resulted in US$ 4.5 billion in complementary financing unlocked from development finance institutions, up to US$ 200 million in cost savings for Gavi-supported programmes announced by vaccine manufacturers – alongside other innovation and supply commitments that will further boost equitable access to critical vaccines, and a range of private sector partnerships aimed at transforming immunisation systems in lower-income countries – including a US$ 40 million anchor commitment towards a new Innovation Scale-Up Fund.

Today’s commitments bring Gavi a major step closer to securing the resources it needs for Gavi 6.0, in which it hopes to protect 500 million children from preventable disease, averting between 8-9 million future deaths, protecting the world from deadly outbreaks of diseases such as cholera, mpox and Ebola through its vaccine stockpiles and unlocking US$ 100 billion in economic benefits for countries.